SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037503
Filing Date
2022-11-14
Accepted
2022-11-14 08:31:03
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20220930.htm   iXBRL 10-Q 2782802
2 EX-10.2 logc-ex102_132.htm EX-10.2 928301
3 EX-31.1 logc-ex311_9.htm EX-31.1 18754
4 EX-31.2 logc-ex312_6.htm EX-31.2 18492
5 EX-32.1 logc-ex321_8.htm EX-32.1 7614
  Complete submission text file 0001564590-22-037503.txt   8329440

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA logc-20220930.xsd EX-101.SCH 41166
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20220930_cal.xml EX-101.CAL 44899
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20220930_def.xml EX-101.DEF 121141
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20220930_lab.xml EX-101.LAB 330649
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20220930_pre.xml EX-101.PRE 248029
57 EXTRACTED XBRL INSTANCE DOCUMENT logc-10q_20220930_htm.xml XML 1022356
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 221380617
SIC: 2836 Biological Products, (No Diagnostic Substances)